Prosecution Insights
Last updated: April 19, 2026

Examiner: RAMOS LEWIS, JOSMALEN MILAGROS

Tech Center 1600 • Art Units: 1621

This examiner grants 54% of resolved cases

Performance Statistics

53.6%
Allow Rate
-6.4% vs TC avg
87
Total Applications
+24.4%
Interview Lift
928
Avg Prosecution Days
Based on 56 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
24.4%
§102 Novelty
51.8%
§103 Obviousness
14.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19313605 TOPICAL OCULAR DELIVERY OF CROMAKALIM Non-Final OA MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
19067074 COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER Final Rejection GSKB Pharmaceuticals, LLC
17436882 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE Final Rejection University of Virginia Patent Foundation
17396292 GREEN POLYETHYLENE WAX FOR HOT MELT ADHESIVES, COATINGS, AND COSMETICS Final Rejection Braskem S.A.
17387518 FUMIGANT COMPOSITION FOR PEST CONTROL Final Rejection National Chung Hsing University
18594178 Chlorthalidone Compositions And Methods Final Rejection Nivagen Pharmaceuticals, Inc.
17599210 METHODS FOR THE TREATMENT OF KELOID, HYPERTROPHIC SCARS AND/OR HYPERPIGMENTATION DISORDERS Non-Final OA ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP)
18031103 2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS Non-Final OA University College Cardiff Consultants Limited
17270609 COMPOSITION CONTAINING PLASMALOGEN FOR ENHANCING MEMORIZATION ABILITY Non-Final OA SUNSHO PHARMACEUTICAL CO., LTD.
18027036 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Non-Final OA HISUN ACCURAY THERAPEUTICS CO., LTD.
17936058 METHOD FOR REDUCING LUNG INFLAMMATION Final Rejection Respirion Pharmaceuticals Pty Ltd
17274773 Use of Casein Kinase 1 Inhibitors For Treating Vascular Diseases Non-Final OA Qanatpharma AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month